PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 6, 2026JAMA Surgery0 citations

Trends in Metabolic and Bariatric Surgery Use During the GLP-1 Receptor Agonist Era

View Full Paper
SRStefanie RohdeGCGrace F. ChaoRMRobert E. Merritt

Key Points

  • To analyze how the use of metabolic and bariatric surgery trends correlate with the increasing use of GLP-1 receptor agonists through 2025.
  • Conducted a cross-sectional analysis of surgery use trends.
  • Collected data on metabolic and bariatric surgeries.
  • Evaluated the correlation with GLP-1 receptor agonist use.
  • Identified an increasing trend in the adoption of surgeries correlated with GLP-1 receptor use.
  • Noted shifts in surgical preference due to medication availability.

Abstract

This cross-sectional analysis examines trends through 2025 in the use of metabolic and bariatric surgery during a period of increasing use of glucagon-like peptide-1 (GLP-1) receptor agonists.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Rohde et al. (2026) studied this question.

synapsesocial.com/papers/69aa7066531e4c4a9ff5a23dhttps://doi.org/10.1001/jamasurg.2026.0049
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes2016 · 6,848 citations
  2. 2Bias Due to Changes in Specified Outcomes during the Systematic Review Process2010 · 168 citations
  3. 3Weight loss between glucagon‐like peptide‐1 receptor agonists and bariatric surgery in adults with obesity: A systematic review and meta‐analysis2022 · 129 citations
  4. 4Metabolic Bariatric Surgery in the Era of GLP-1 Receptor Agonists for Obesity Management2024 · 70 citations
  5. 5Great Debates: Undergoing the Knife versus Pill-Popping—The Comparative Efficacy and Cost-Effectiveness of Bariatric Surgery and GLP-1 Receptor Agonists in the Management of Obesity2025 · 17 citations